Medicare Enrolled
Dr. Beth Hodges, MD
Family Medicine · Asheboro, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hodges from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hodges?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hodges
Dr. Beth Hodges is a family medicine specialist in Asheboro, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hodges performed 1,659 Medicare services across 796 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hodges received a total of $22,484 from 58 pharmaceutical and/or device companies across 665 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hodges is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 16% volume in NC
$22,484 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,659
Medicare services
Top 16% in NC for family medicine
796
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~87 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
379 | $80 | $205 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
374 | $39 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
129 | $55 | $150 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
82 | $34 | $50 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
71 | $32 | $125 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
67 | $16 | $50 |
| Annual depression screening | 67 | $17 | $25 |
| Annual alcohol misuse screening, 5 to 15 minutes | 66 | $17 | $25 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
62 | $116 | $175 |
| Annual intensive behavioral therapy for cardiovascular disease, 15 minutes A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually. |
60 | $24 | $25 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
43 | $3 | $25 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
41 | $16 | $40 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
40 | $41 | $45 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
38 | $31 | $75 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
32 | $2 | $30 |
| Urine microalbumin test A laboratory test that measures the amount of a specific protein called microalbumin in a urine sample. This analysis helps assess kidney function. |
31 | $6 | $35 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
19 | $135 | $250 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
19 | $12 | $50 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
15 | $6 | $35 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
13 | $208 | $285 |
| Stool test for blood to screen for colon tumors A test that analyzes a stool sample to detect hidden blood, which is used to screen for colon tumors. |
11 | $4 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,484
Total received (2018-2024)
Avg $3,212/year across 7 years
Top 1% in NC for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
665
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,318 (50.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,966 (44.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,200 (5.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,415
2023
$1,660
2022
$1,694
2021
$1,697
2020
$1,155
2019
$5,072
2018
$9,791
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$214
Corcept Therapeutics
$148
ABBVIE INC.
$145
Astellas Pharma US Inc
$144
GlaxoSmithKline, LLC.
$124
Lilly USA, LLC
$70
AstraZeneca Pharmaceuticals LP
$70
Axsome Therapeutics, Inc.
$66
PFIZER INC.
$58
Lundbeck LLC
$45
Janssen Pharmaceuticals, Inc
$45
Merck Sharp & Dohme LLC
$39
Sumitomo Pharma America, Inc.
$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$35
Amgen Inc.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Exact Sciences Corporation
$22
Paratek Pharmaceuticals, Inc.
$21
Dexcom, Inc.
$20
Otsuka America Pharmaceutical, Inc.
$16
Mylan Specialty L.P.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Top 3 companies account for 35.8% of 2024 payments
All-time payments by company (2018-2024) ›
Sunovion Pharmaceuticals Inc.
$9,966
Sensible Medical Innovations Inc
$2,124
Novo Nordisk Inc
$1,798
AstraZeneca Pharmaceuticals LP
$1,780
Lilly USA, LLC
$997
GlaxoSmithKline, LLC.
$627
Boehringer Ingelheim Pharmaceuticals, Inc.
$534
ABBVIE INC.
$485
Novartis Pharmaceuticals Corporation
$425
Astellas Pharma US Inc
$376
Bayer HealthCare Pharmaceuticals Inc.
$309
Amgen Inc.
$235
Bayer Healthcare Pharmaceuticals Inc.
$225
Janssen Pharmaceuticals, Inc
$182
Corcept Therapeutics
$163
Amarin Pharma Inc.
$157
PFIZER INC.
$154
Mylan Specialty L.P.
$152
AbbVie Inc.
$127
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$115
Merck Sharp & Dohme Corporation
$92
SANOFI-AVENTIS U.S. LLC
$89
Neurocrine Biosciences, Inc.
$88
Lundbeck LLC
$83
Takeda Pharmaceuticals U.S.A., Inc.
$80
Otsuka America Pharmaceutical, Inc.
$68
Axsome Therapeutics, Inc.
$66
Abbott Laboratories
$66
Nestle HealthCare Nutrition Inc.
$63
Dexcom, Inc.
$62
Genentech USA, Inc.
$54
Eisai Inc.
$48
Exact Sciences Corporation
$45
Esperion Therapeutics, Inc.
$41
Merck Sharp & Dohme LLC
$39
Sumitomo Pharma America, Inc.
$38
Novavax Inc
$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$35
Avanir Pharmaceuticals, Inc.
$35
Corium, LLC
$34
ARBOR PHARMACEUTICALS, INC.
$34
Cranial Technologies, Inc
$34
Biohaven Pharmaceuticals, Inc.
$33
Radius Health, Inc.
$33
Renalytix AI, Inc.
$30
Boston Scientific Corporation
$26
Ironwood Pharmaceuticals, Inc
$25
IDORSIA PHARMACEUTICALS US INC
$23
EISAI INC.
$21
Paratek Pharmaceuticals, Inc.
$21
Alexion Pharmaceuticals, Inc.
$16
Biohaven Pharmaceutical Holding Company Ltd.
$16
Melinta Therapeutics, Inc.
$15
Daiichi Sankyo Inc.
$15
Medtronic, Inc.
$14
Allergan Inc.
$13
E.R. Squibb & Sons, L.L.C.
$13
OPKO Pharmaceuticals, LLC
$11
Top 3 companies account for 61.8% of all-time payments
Associated products mentioned in payments ›
ADJUVANTED · AMYVID · ANORO · Adlarity · Aduhelm · Aimovig · Amitiza · Auvelity · BASAGLAR · BELSOMRA · BEXSERO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · Baxdela · Belviq · CAPLYTA · COMIRNATY · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · Doc Band · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · GARDASIL · GARDASIL 9 · GEMTESA · GENERAL - PAIN MANAGEMENT · Horizant · INGREZZA · INJECTAFER · INTELLIS ADAPTIVESTIM · INVEGA SUSTENNA · INVOKANA · JANUVIA · JARDIANCE · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · Leqembi · Linzess · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NOVAVAX COVID-19 VACCINE · NUEDEXTA · NURTEC ODT · NUZYRA · Otezla · Ozempic · PAXLOVID · PREMARIN · PREVNAR 20 · PROCLAIM · Proclaim Family of SCS IPGs · Prolia · QULIPTA · QUVIVIQ · RAYALDEE · REXULTI · ROTATEQ · RYBELSUS · ReDS system · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SPRAVATO · STIOLTO RESPIMAT · STRENSIQ · SYMBICORT · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · UTIBRON · Utibron · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza · Xultophy 100/3.6 · YUPELRI · Yupelri · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (50%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in NC.
Geographic Context
Family medicine physicians within 10 mi
238
Per 100K population
163.8
County median income
$59,047
Nearest hospital
RANDOLPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hodges is a clinical cardiology specialist, with above-average Medicare volume (top 16% in NC), with low-engagement industry engagement in the top 1% of NC peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hodges experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hodges performed 379 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hodges receive payments from pharmaceutical companies?
Yes. Dr. Hodges received a total of $22,484 from 58 companies across 665 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hodges's costs compare to other family medicine physicians in Asheboro?
Dr. Hodges's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hodges) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Asheboro
Browse family medicine physicians in Asheboro ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NC
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NC
Which NC family medicine physicians receive the most from drug and device companies.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
By company
Sensible Medical Innovations Inc Payments to Doctors
See all physicians who received payments from Sensible Medical Innovations Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology